Corvus Pharmaceuticals (NASDAQ:CRVS) Research Coverage Started at Oppenheimer theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) Short Interest Down 17 7% in July theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.56 and traded as low as $2.04. Corvus Pharmaceuticals shares last traded at $2.24, with a volume of 113,815 shares changing hands. Analysts Set […]
Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) had its price objective boosted by LADENBURG THALM/SH SH from $10.00 to $12.00 in a report issued on Monday, FlyOnTheWall reports. CRVS has been the topic of a number of other reports. StockNews.com began coverage on shares of Corvus Pharmaceuticals in a report on Thursday, May 18th. They set […]
Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) had its target price raised by LADENBURG THALM/SH SH from $10.00 to $12.00 in a research report sent to investors on Monday, FlyOnTheWall reports. CRVS has been the subject of a number of other research reports. Cantor Fitzgerald raised their price objective on shares of Corvus Pharmaceuticals from $2.00 […]